NSE · BPLPHARMA
Bharat Parenterals Limited (BPLPHARMA) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,353
of 5,047 stocks
🏆 New peak
▲ 691W▲ 981M
Peak #1,353 · 17 Nov 2026
Operating in Healthcare, Bharat Parenterals Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 67%.
Market Cap
1,525.61 Cr
P/E Ratio
55.87
P/B Ratio
4.90
ROE
-8.76%
ROCE
-1.95%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 136.28 Cr | 93.74 Cr | 99.62 Cr | 65.19 Cr |
| Net Profit | 11.82 Cr | -3.56 Cr | -8.16 Cr | -9.67 Cr |
| EPS | 17.15 | 5.17 | 11.84 | 14.03 |
| Operating Profit | 17.11 Cr | 95.92 L | -5.53 Cr | -5.39 Cr |
Shareholding pattern
Promoter
67.20%
Public
32.80%
PUBLIC BREAKDOWN
FII
0.11%
DII
1.37%
Individuals
22.23%
Mutual fund holdings
₹1.02
Cr total
1
Schemes
1
Fund Houses
₹1.02 Cr
Total Exposure
WhiteOak Capital Mutual Fund₹1.02 Cr (100.0%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
No corporate actions on record for this stock.
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.